05/28/2026
Pioneering the future of heart care! The Jewish Hospital — Mercy Health celebrates its first coronary reactivity test, which measures coronary flow reserve (CFR) to assess small-vessel disease and spasm in larger vessels.
Unlike traditional cardiac testing that focuses mainly on large coronary arteries, CFR testing can help identify coronary microvascular disease, a condition affecting the heart’s smallest blood vessels that often goes undetected. This technology gives physicians deeper insight into blood flow abnormalities, helping improve diagnosis, guide treatment decisions and personalize patient care.
This milestone reflects the continued commitment to bringing innovative cardiovascular care and advanced diagnostic capabilities to our community.